We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -2.01% | 9.75 | 9.55 | 10.50 | 9.75 | 9.75 | 9.75 | 61,764 | 10:02:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.87 | 56.92M |
TIDMETX TIDMAV.
RNS Number : 0203U
e-Therapeutics plc
12 January 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or e-Therapeutics plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- ------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------- ---------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------- ---------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------- ---------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------- ---------------------------------- Other (please specify): ----------------------------------------------------------- ------- ---------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- ----------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) BNY Norwich Union Nominees Limited 3,309,498* Chase (GA Group) Nominees Limited 37,607,733* * denotes direct interest Chase Nominees Limited 1,625,637 ------------------------------------------------------------- ----------------------------------------- 5. Date of the transaction 10 January 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- ----------------------------------------- 6. Date on which issuer 11 January 2017 notified: ------------------------------------------------------------- ----------------------------------------- 7. Threshold(s) that is/are 16% to 15% Change at Combined crossed or Interest Level reached: (vi, vii) ------------------------------------------------------------- ----------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ----------------- ------------------------------ ----------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ----------------- ----------------- ----------- ------------- ------------------------ ------------------ Direct Direct Indirect Direct Indirect (xi) (xii) ----------------- ----------------- ----------- ------------- ----------- ----------- ------- --------- Ordinary Shares GB00B2823H99 44,073,702 44,073,702 42,542,868 40,917,231 1,625,637 15.24% 0.61% ----------------- ----------- ------------- ----------- ----------- ------- --------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ----------------- -------------------------- ------------------------ ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 42,542,868 15.85% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------ The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: ------------------------------------------------------------------------------ 10. Name of the proxy holder: See Section 4 --------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------- ------------------------------- 13. Additional information: Figures are based on the total number of voting rights of 268,426,042 as per the Company's Issue of Equity Announcement of 4 January 2017. --------------------------------------------- ------------------------------- 14. Contact name: Neil Whittaker, Aviva plc --------------------------------------------- ------------------------------- 15. Contact telephone number: 01603 684420 --------------------------------------------- -------------------------------
The company news service from the London Stock Exchange
END
HOLEAEFAFDSXEFF
(END) Dow Jones Newswires
January 12, 2017 05:38 ET (10:38 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions